Fang, C.-Y.; Chen, S.-H.; Huang, C.-C.; Liao, Y.-W.; Chao, S.-C.; Yu, C.-C.
Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis. Pharmaceuticals 2022, 15, 833.
https://doi.org/10.3390/ph15070833
AMA Style
Fang C-Y, Chen S-H, Huang C-C, Liao Y-W, Chao S-C, Yu C-C.
Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis. Pharmaceuticals. 2022; 15(7):833.
https://doi.org/10.3390/ph15070833
Chicago/Turabian Style
Fang, Chih-Yuan, Szu-Han Chen, Chun-Chung Huang, Yi-Wen Liao, Shih-Chi Chao, and Cheng-Chia Yu.
2022. "Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis" Pharmaceuticals 15, no. 7: 833.
https://doi.org/10.3390/ph15070833
APA Style
Fang, C.-Y., Chen, S.-H., Huang, C.-C., Liao, Y.-W., Chao, S.-C., & Yu, C.-C.
(2022). Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis. Pharmaceuticals, 15(7), 833.
https://doi.org/10.3390/ph15070833